Course Provider
Learning Objectives
1.Recognize disparities in transplantation and propose plans to improve equity, as well as provide resources to expand access to care.
2.Examine the various posttransplant mixed chimerism monitoring techniques and realize their role in forecasting long-term outcomes.
3.Bring awareness through education of the effects of the opioid epidemic on the donor organ supply, solid organ waiting lists, transplant candidacy and posttransplant outcomes.
4.Recognize the potential of nanotechnology to aid in the therapeutic delivery of immunosuppressive agents.
5.Consider the effectiveness and safety of CAR T-cell therapy versus autologous hematopoietic stem cell transplantation in patients with relapsed lymphoma.
6.Implement a multidisciplinary clinical team approach with strategies that specialize in the management of intestinal rehabilitation and transplantation.
7.Utilize the National Comprehensive Cancer Network guidelines to help determine the most appropriate biomarkers and assays to use for diagnostic testing practices for non-small cell lung cancer.
8.Determine the relationship between tumor development and intestinal microbiota and how alterations in the composition of the gut microbes influence the tumor microbiota and the tumor microenvironment affecting cancer progression.
9.Incorporate practices that assist in processing grief around trauma and loss related to patient care and treating illness.
10.Identify and evaluate strategies to promote recruitment and retention of racial and ethnic minorities in clinical trials.